Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Willenbacher W"'
Autor:
Reimann P; Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria.; Private University of the Principality of Liechtenstein, Triesen, Principality of Liechtenstein., Petzer V; Innsbruck University Hospital, Internal Medicine V: Haematology & Oncology, Innsbruck, Austria., Mündlein A; Molecular Biology Laboratory, Vorarlberg Institute for Vascular Investigation and Treatment, Dornbirn, Austria., Hartmann B; Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria., Severgnini L; Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria.; Private University of the Principality of Liechtenstein, Triesen, Principality of Liechtenstein., Winkler A; Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria., Lang T; Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria., Huynh M; Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria., Gasser K; Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria., Rüger J; Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria., Atzl M; Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria., Mink S; Private University of the Principality of Liechtenstein, Triesen, Principality of Liechtenstein.; Medical Central Laboratories, Feldkirch, Austria., Fraunberger P; Medical Central Laboratories, Feldkirch, Austria., Schmidt S; Innsbruck University Hospital, Internal Medicine V: Haematology & Oncology, Innsbruck, Austria., Steiner N; Innsbruck University Hospital, Internal Medicine V: Haematology & Oncology, Innsbruck, Austria., Griesmacher A; Central Institute for Med. and Chem. Laboratory Diagnostics (ZIMCL) With Interdisciplinary Hematological Competence Centre (IHK), Medical University Innsbruck, Innsbruck, Austria., Gunsilius E; Innsbruck University Hospital, Internal Medicine V: Haematology & Oncology, Innsbruck, Austria., Nachbaur D; Innsbruck University Hospital, Internal Medicine V: Haematology & Oncology, Innsbruck, Austria., Willenbacher W; Innsbruck University Hospital, Internal Medicine V: Haematology & Oncology, Innsbruck, Austria.; Syndena,GmbH Connect to Cure, Innsbruck, Austria., Wolf D; Innsbruck University Hospital, Internal Medicine V: Haematology & Oncology, Innsbruck, Austria., Winder T; Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria.; University of Zurich, Zurich, Switzerland., Benda MA; Department of Internal Medicine II, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800, Feldkirch, Austria. magdalena.benda@lkhf.at.; Private University of the Principality of Liechtenstein, Triesen, Principality of Liechtenstein. magdalena.benda@lkhf.at.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 Jun; Vol. 103 (6), pp. 2123-2131. Date of Electronic Publication: 2024 Mar 02.
Autor:
Ludwig H; Wilhelminen Cancer Research Institute c/o Department of Medicine I, Clinic Ottakring Vienna Austria., Melchardt T; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Cancer Cluster Salzburg Salzburg Austria., Schweitzer I; Wilhelminen Cancer Research Institute c/o Department of Medicine I, Clinic Ottakring Vienna Austria., Sormann S; Department of Hematology University Clinic for Internal Medicine Graz Austria., Schreder M; Department of Medicine I Clinic Ottakring Vienna Austria., Andel J; Department of Internal Medicine II Pyhrn-Eisenwurzen Klinikum Steyr Steyr Austria., Hartmann B; Department of Internal Medicine II LKH Rankweil Salzburg Austria., Zojer N; Department of Medicine I Clinic Ottakring Vienna Austria., Schöffmann L; Department for Hematology, Oncology and Palliative Care LKH Hochsteiermark, Standort Leoben Leoben Austria., Gunsilius E; Department of Internal Medicine V Medical University Innsbruck Innsbruck Austria., Podar K; Department of Internal Medicine II, University Hospital Krems; and Molecular Oncology and Hematology Unit Karl Landsteiner University of Health Sciences, Krems an der Donau Krems Austria., Egle A; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Cancer Cluster Salzburg Salzburg Austria., Willenbacher W; Department of Internal Medicine V Medical University Innsbruck Innsbruck Austria.; Syndena GmbH Connect to Cure Innsbruck Austria., Wöll E; Department of Internal Medicine St. Vinzenz Krankenhaus Zams Zams Austria., Ruckser R; Department of Medicine II Clinic Donaustadt Vienna Austria., Bozic B; Department of Medicine II Clinic Donaustadt Vienna Austria., Krauth MT; University Clinic for Internal Medicine I AKH, Medical University of Vienna Vienna Austria., Petzer A; Department of Internal Medicine I BHS Linz Linz Austria., Schmitt C; Clinic for Internal Medicine 3 Kepler University Clinic Linz Linz Austria., Machherndl-Spandl S; Department of Internal Medicine I Elisabethinen, Linz Linz Austria., Agis H; Department of Internal Medicine I, Division of Oncology Medical University Vienna Vienna Austria., Fillitz M; Department of Internal Medicine Hanusch Krankenhaus Vienna Austria., Wang SY; Medical Clinic and Policlinic I University Clinic Leipzig Leipzig Germany., Knop S; Klinik für Innere Medizin 5, Schwerpunkt Onkologie/Hämatologie Klinikum Nürnberg Nord Nürnberg Germany., Greil R; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Cancer Cluster Salzburg Salzburg Austria.
Publikováno v:
EJHaem [EJHaem] 2024 May 17; Vol. 5 (3), pp. 494-504. Date of Electronic Publication: 2024 May 17 (Print Publication: 2024).
Autor:
Ludwig H; Department of Medicine I, Clinic Ottakring, Wilhelminen Cancer Research Institute, Vienna, Austria., Melchardt T; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria., Sormann S; Department of Hematology, University Clinic for Internal Medicine, Graz, Austria., Schreder M; Department of Medicine I, Clinic Ottakring, Vienna, Austria., Andel J; Department of Internal Medicine II, Pyhrn-Eisenwurzen Klinikum Steyr, Steyr, Austria., Hartmann B; Department of Internal Medicine II, LKH Rankweil, Rankweil, Austria., Tinchon C; Department for Hematology, Oncology and Palliative Care, LKH Hochsteiermark, Standort Leoben, Standort Leoben, Austria., Zojer N; Department of Medicine I, Clinic Ottakring, Vienna, Austria., Gunsilius E; Department of Internal Medicine V, Medical University Innsbruck, Innsbruck, Austria., Podar K; Department of Internal Medicine II, University Hospital Krems, Krems an der Donau, Austria.; Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria., Egle A; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria., Willenbacher W; Department of Internal Medicine V, Medical University Innsbruck, Innsbruck, Austria.; syndena GmbH, Connect to Cure, Innsbruck, Austria., Wöll E; Department of Internal Medicine, St. Vinzenz Krankenhaus Zams, Zams, Austria., Ruckser R; Department of Medicine II, Clinic Donaustadt, Vienna, Austria., Bozic B; Department of Medicine II, Clinic Donaustadt, Vienna, Austria., Krauth MT; University Clinic for Internal Medicine I, AKH, Medical University of Vienna, Vienna, Austria., Petzer A; Department of Internal Medicine I, BHS Linz, Linz, Austria., Schmitt C; Clinic for Internal Medicine 3, Kepler University Clinic Linz, Linz, Austria., Machherndl-Spandl S; Department of Internal Medicine I, Elisabethinen, Linz, Austria., Agis H; Department of Internal Medicine I, Division of Oncology, Medical University Vienna, Vienna, Austria., Fillitz M; Department of Internal Medicine, Hanusch Krankenhaus, Vienna, Austria., Wang SY; Medical Clinic and Policlinic I, University Clinic Leipzig, Leipzig, Germany., Zabernigg A; Department of Internal Medicine, Kufstein County Hospital, Kufstein, Austria., Knop S; Klinik für Innere Medizin 5, Schwerpunkt Onkologie/Hämatologie, Klinikum Nürnberg Nord, Nürnberg, Germany., Paiva B; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), CCUN, IDISNA, Pamplona, Spain., Greil R; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 May; Vol. 99 (5), pp. 1008-1011. Date of Electronic Publication: 2024 Feb 29.
Autor:
Brunner A; Department of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria. andrea.brunner@i-med.ac.at., Thalhammer-Thurner GC; Department of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria., Willenbacher W; Internal Medicine V, Haematology & Oncology, Innsbruck Medical University, Innsbruck, Austria.; Syndena GmbH, Connect to Cure, Innsbruck, Austria., Haun M; Department of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria.; Institute of Pathophysiology, Innsbruck Medical University, Innsbruck, Austria., Zelger BG; Department of Pathology, Neuropathology and Molecular Pathology, Innsbruck Medical University, Innsbruck, Austria., Willenbacher E; Internal Medicine V, Haematology & Oncology, Innsbruck Medical University, Innsbruck, Austria.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 Feb; Vol. 103 (2), pp. 553-563. Date of Electronic Publication: 2023 Nov 11.
Autor:
Rensing-Ehl A; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Electronic address: anne.rensing-ehl@uniklinik-freiburg.de., Lorenz MR; Institute for Transfusion Medicine, University of Ulm, Ulm, Germany., Führer M; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service Baden-Wuerttemberg - Hessen, Ulm, Germany., Willenbacher W; Clinic for Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria; Syndena GmbH, Connect to cure, Innsbruck, Austria., Willenbacher E; Clinic for Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria., Sopper S; Clinic for Internal Medicine V, Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria; Tyrolean Cancer Research Institute, Innsbruck, Austria., Abinun M; Paediatric Immunology, Great North Children's Hospital, Newcastle University, Newcastle upon Tyne, United Kingdom., Maccari ME; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Mathildenstr. 1, Freiburg, Germany., König C; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Faculty of Biology, University of Freiburg, Schaenzlestrasse 1, Freiburg, Germany., Haegele P; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Fuchs S; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Castro C; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Kury P; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Pelle O; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Université Paris Cité, INSERM UMR 1163, Imagine Institute, Paris, France., Klemann C; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Heeg M; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Thalhammer J; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Paediatric Immunology, Great North Children's Hospital, Newcastle University, Newcastle upon Tyne, United Kingdom., Wegehaupt O; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Mathildenstr. 1, Freiburg, Germany., Fischer M; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Mathildenstr. 1, Freiburg, Germany., Goldacker S; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Schulte B; Center for Human Genetics, Paul-Ehrlich-Str. 23, Tuebingen, Germany., Biskup S; Center for Human Genetics, Paul-Ehrlich-Str. 23, Tuebingen, Germany., Chatelain P; Center for Human Genetics, Paul-Ehrlich-Str. 23, Tuebingen, Germany., Schuster V; Children's Hospital, Faculty of Medicine, University of Leipzig, Leipzig, Germany., Warnatz K; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Clinic for Rheumatolgy and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Grimbacher B; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Clinic for Rheumatolgy and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; DZIF - German Center for Infection Research, Satellite Center Freiburg, Freiburg, Germany; CIBSS - Centre for Integrative Biological Signalling Studies, Albert-Ludwigs University, Freiburg, Germany; RESIST - Cluster of Excellence 2155 to Hannover Medical School, Satellite Center Freiburg, Freiburg, Germany., Meinhardt A; Center for Pediatrics and Adolescent Medicine, Department of Pediatric Oncology, Hematology and Immunodeficiencies, University Hospital Giessen, Giessen, Germany., Holzinger D; Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany; Department of Applied Health Sciences, University of Applied Sciences Bochum, Bochum, Germany., Oommen PT; Department of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Hinze T; Department of Pediatric Rheumatology and Immunology, University Hospital Münster, Münster, Germany., Hebart H; Department of Internal Medicine, Kliniken Ostalb, Stauferklinikum, Mutlangen, Germany., Seeger K; Charité Universitätsmedizin Berlin, Department of Pediatric Oncology/Hematology, Augustenburger Pl. 1, Berlin, Germany., Lehmberg K; Department of Paediatric Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Leahy TR; Department of Paediatric Immunology/ID, Children's Health Ireland (CHI) at Crumlin, Dublin; University of Dublin, Trinity College, Dublin, Ireland., Claviez A; Department of Pediatrics, University Medical Center, UKSH Campus Kiel, Kiel, Germany., Vieth S; Department of Pediatrics, University Medical Center, UKSH Campus Kiel, Kiel, Germany., Schilling FH; Department of Pediatric Oncology-Hematology-Immunology, Children's Hospital Lucerne, Lucerne, Switzerland., Fuchs I; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Groß M; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Rieux-Laucat F; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Université Paris Cité, INSERM UMR 1163, Imagine Institute, Paris, France., Magerus A; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Université Paris Cité, INSERM UMR 1163, Imagine Institute, Paris, France., Speckmann C; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Mathildenstr. 1, Freiburg, Germany., Schwarz K; Institute for Transfusion Medicine, University of Ulm, Ulm, Germany; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service Baden-Wuerttemberg - Hessen, Ulm, Germany., Ehl S; Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Jan; Vol. 153 (1), pp. 297-308.e12. Date of Electronic Publication: 2023 Nov 17.
Autor:
Zelger P; University Hospital of Hearing, Voice and Speech Disorders, Medical University of Innsbruck, Innsbruck, Austria., Brunner A; Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria., Zelger B; Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria., Willenbacher E; University Hospital of Internal Medicine V, Hematology & Oncology, Medical University of Innsbruck, Innsbruck, Austria., Unterberger SH; Institute of Material-Technology, Leopold-Franzens University Innsbruck, Innsbruck, Austria., Stalder R; Institute of Mineralogy and Petrography, Leopold-Franzens University Innsbruck, Innsbruck, Austria., Huck CW; Institute of Analytical Chemistry and Radiochemistry, Innsbruck, Austria., Willenbacher W; University Hospital of Internal Medicine V, Hematology & Oncology, Medical University of Innsbruck, Innsbruck, Austria.; Oncotyrol, Centre for Personalized Cancer Medicine, Innsbruck, Austria., Pallua JD; University Hospital for Orthopedics and Traumatology, Medical University of Innsbruck, Innsbruck, Austria.
Publikováno v:
Journal of biophotonics [J Biophotonics] 2023 Nov; Vol. 16 (11), pp. e202300015. Date of Electronic Publication: 2023 Aug 23.
Autor:
Ansell SM; Mayo Clinic, Rochester, MN., Bröckelmann PJ; University of Cologne, Cologne, Germany and Center for Integrated Oncology Aachen Bonn Duesseldorf, Bonn, Germany., von Keudell G; Memorial Sloan Kettering Cancer Center, New York, NY., Lee HJ; University of Texas MD Anderson Cancer Center, Houston, TX., Santoro A; Humanitas University, Pieve Emanuele, Milan, Italy and IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Rozzano, Milan, Italy., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Instituto di Ematologia 'Seràgnoli' and Università di Bologna, Bologna, Italy., Collins GP; Churchill Hospital, Oxford, United Kingdom., Cohen JB; Winship Cancer Institute, Atlanta, GA., de Boer JP; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Kuruvilla J; Princess Margaret Cancer Centre, Toronto, ON, Canada., Savage KJ; BC Cancer, Vancouver, BC, Canada., Trněný M; Charles University in Prague, Prague, Czech Republic., Provencio M; University Hospital Puerta de Hierro, Majadahonda, Spain., Jäger U; Medical University of Vienna, Vienna, Austria., Willenbacher W; Innsbruck Medical University and Sydena GmbH, Connect to Cure, Innsbruck, Austria., Wen R; Bristol Myers Squibb, Princeton, NJ., Akyol A; Bristol Myers Squibb, Princeton, NJ., Mikita-Geoffroy J; Bristol Myers Squibb, Boudry, Switzerland., Shipp MA; Dana-Farber Cancer Institute, Boston, MA., Engert A; University of Cologne, Cologne, Germany and Center for Integrated Oncology Aachen Bonn Duesseldorf, Bonn, Germany., Armand P; Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2023 Oct 24; Vol. 7 (20), pp. 6266-6274.
Autor:
Lehmann J; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.; Syndena GmbH, Innsbruck, Austria., de Ligt KM; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, Netherlands., Tipelius S; Syndena GmbH, Innsbruck, Austria., Giesinger JM; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Sztankay M; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria., Voigt S; Syndena GmbH, Innsbruck, Austria.; Internal Medicine V: Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria., van de Poll-Franse LV; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Department of Medical and Clinical Psychology, Center of Research on Psychological and Somatic Disorders (CoRPS), Tilburg University, Tilburg, Netherlands., Rumpold G; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.; Evaluation Software Development GmbH, Innsbruck, Austria., Weger R; Syndena GmbH, Innsbruck, Austria., Willenbacher E; Internal Medicine V: Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria., Willenbacher W; Syndena GmbH, Innsbruck, Austria.; Internal Medicine V: Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria., Holzner B; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.; Evaluation Software Development GmbH, Innsbruck, Austria.
Publikováno v:
Journal of medical Internet research [J Med Internet Res] 2023 Aug 22; Vol. 25, pp. e46017. Date of Electronic Publication: 2023 Aug 22.
Autor:
Kreitman RJ; Laboratory of Molecular Biology, National Institutes of Health, Bethesda, MD., Moreau P; Department of Hematology, CHU de Nantes, Nantes, France., Ravandi F; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Hutchings M; Department of Haematology and Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark., Gazzah A; Gustave Roussy Cancer Institute, Villejuif, France., Michallet AS; Centre Léon Bérard, Lyon, France., Wainberg ZA; Department of Medicine, UCLA, Los Angeles, CA., Stein A; Department of Internal Medicine II (Oncology Center), University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Dietrich S; University of Heidelberg, Heidelberg, Germany., de Jonge MJA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Willenbacher W; Internal Medicine V: Hematology & Oncology, Medical University Innsbruck, Innsbruck, Austria.; Oncotyrol-Center for Personalized Cancer Medicine, Innsbruck, Austria., De Grève J; University Hospital Vrije Universiteit Brussel, Brussels, Belgium., Arons E; Laboratory of Molecular Biology, National Institutes of Health, Bethesda, MD., Ilankumaran P; Global Drug Development, Oncology Development Unit, Novartis Pharmaceuticals Corporation, East Hanover, NJ., Burgess P; Global Drug Development, Oncology Development Unit, Novartis Pharma AG, Basel, Switzerland., Gasal E; Global Drug Development, Oncology Development Unit, Novartis Pharmaceuticals Corporation, East Hanover, NJ., Subbiah V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Blood [Blood] 2023 Mar 02; Vol. 141 (9), pp. 996-1006.
Autor:
Locher M; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Jukic E; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Vogi V; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Keller MA; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Kröll T; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Schwendinger S; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Oberhuber K; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Verdorfer I; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Mühlegger BE; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Witsch-Baumgartner M; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Nachbaur D; Internal Medicine V (Hematology & Oncology), Medical University of Innsbruck, Innsbruck, Austria., Willenbacher W; Internal Medicine V (Hematology & Oncology), Medical University of Innsbruck, Innsbruck, Austria.; syndena GmbH, connect to cure, Innsbruck, Austria., Gunsilius E; Internal Medicine V (Hematology & Oncology), Medical University of Innsbruck, Innsbruck, Austria., Wolf D; Internal Medicine V (Hematology & Oncology), Medical University of Innsbruck, Innsbruck, Austria.; Medical Clinic 3, Oncology, Hematology, Immunoncology and Rheumatology, University Hospital Bonn, Bonn, Germany., Zschocke J; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Steiner N; Internal Medicine V (Hematology & Oncology), Medical University of Innsbruck, Innsbruck, Austria.
Publikováno v:
European journal of haematology [Eur J Haematol] 2023 Mar; Vol. 110 (3), pp. 296-304. Date of Electronic Publication: 2022 Dec 04.